Document Type : Original Article


Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran


Introduction and Aim: Breast Cancer is the most prevalent type of tumor and is also have second major death among women. The aim of the current study was to investigate the anticancer properties of Phormidiumm Animale cyanobacterium extract using MTT assay and through modulation of p53 gene expression in breast cancer cells.
Methods: In the current study, the breast cancer MCF-7 and normal HEK293 cell lines were treated with various concentrations of P. animale extract ranging 50, 100, 200 mg/mL for 24 hours. Cell viability was measured using MTT (3-(4, 5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) assay against cell lines. The gene expressions of p53 compared with GAPDH were measured using the real-time PCR method.
Results: The MTT results showed that P. animale significantly decreased the viability of cancer cells compared to normal cells in dose-dependent mode. Moreover, the mRNA levels of p53 were significantly increased from 3.34 in MCF-7 cells to 5.15 and 9.11 fold, respectively, following treatment with 50, 100, and 200 mg/mL P. animale extract.
Conclusion: The data suggest that P. animale extract can induce cytotoxicity and might modulate apoptosis by up-regulating p53 gene expression in human breast cancer MCF-7 cell line.


Main Subjects

Albeshan, S.M., Mackey, M.G., Hossain, S.Z., Alfuraih, A.A. and Brennan, P.C. 2018. Breast cancer epidemiology in gulf cooperation council countries: A regional and international comparison. Clinical breast cancer, 18(3): e381-e392.
Andersen, R.A. 2005. Algal culturing techniques. Elsevier.
Bajpai, R., Sharma, N.K. and Rai, A.K. 2009. Hepatosplenomegaly and phytotoxicity of a planktonic cyanobacterium nostoc sp. Bhu001 isolated from agricultural pond. World Journal of Microbiology and Biotechnology, 25(11): 1995-2003.
Borges, H., Branco, L., Martins, M., Lima, C., Barbosa, P., Lira, G., Bittencourt-Oliveira, M. and Molica, R. 2015. Cyanotoxin production and phylogeny of benthic cyanobacterial strains isolated from the northeast of brazil. Harmful Algae, 43: 46-57.
Catherine, Q., Susanna, W., Isidora, E.-S., Mark, H., Aurelie, V. and Jean-François, H. 2013. A review of current knowledge on toxic benthic freshwater cyanobacteria–ecology, toxin production and risk management. Water research, 47(15): 5464-5479.
Dejakam, A., Dejakam, A. and Hekmat, A. 2020. Evaluating of bdnf expression in blood cells of opium recovering patients with a new treatment method: A molecular marker. Research in Karyotic Cell &Tissue, 1(1): 16-25.
Gademann, K. and Portmann, C. 2008. Secondary metabolites from cyanobacteria: Complex structures and powerful bioactivities. Current Organic Chemistry, 12(4): 326-341.
Ghoussaini, M., Pharoah, P.D. and Easton, D.F. 2013. Inherited genetic susceptibility to breast cancer: The beginning of the end or the end of the beginning? The American journal of pathology, 183(4): 1038-1051.
Hekmat, A., Afrough, M., Hesami Tackallou, S. and Ahmad, F. 2020. Synergistic effects of titanium dioxide nanoparticles and paclitaxel combination on the DNA structure and their antiproliferative role on mda-mb-231cells. Journal of Nanoanalysis, 7(2): 152-165.
Kern, S.E., Kinzler, K.W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. and Vogelstein, B. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science, 252(5013): 1708-1711.
Lagunas-Cruz, M.d.C., Valle-Mendiola, A., Trejo-Huerta, J., Rocha-Zavaleta, L., Mora-García, M.d.L., Gutiérrez-Hoya, A., Weiss-Steider, B. and Soto-Cruz, I. 2019. Il-2 induces transient arrest in the g1 phase to protect cervical cancer cells from entering apoptosis. Journal of oncology, 2019.
Paul, S., Pal, R. and Kundu, R. 2012. Antiproliferative activity of phormidium valderianum and phormidium tenue (cyanobacteria) on human cervical cancer cells (hela) in vitro. Algal Biomass Utln, 3(4): 30-37.
Salehzadeh, A., Sayyad Delshadpour, F. and Sadat Shandiz, A. 2018. Cytotoxicity effect and changes in the expression of caspase-9 gene in breast cancer cell line (mcf-7) treated with the extract of oscillatoria cyanobacteria. Qom University of Medical Sciences Journal, 12(1): 26-34.
Shiovitz, S. and Korde, L.A. 2015. Genetics of breast cancer: A topic in evolution. Annals of Oncology, 26(7): 1291-1299.
Tan, L.T. 2007. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry, 68(7): 954-979.
Venkitaraman, A.R. 2014. Cancer suppression by the chromosome custodians, brca1 and brca2. Science, 343(6178): 1470-1475.
Vijayakumar, S. and Menakha, M. 2015. Pharmaceutical applications of cyanobacteria—a review. Journal of Acute Medicine, 5(1): 15-23.
Wase, N.V. and Wright, P.C. 2008. Systems biology of cyanobacterial secondary metabolite production and its role in drug discovery. Expert opinion on drug discovery, 3(8): 903-929.